PortfoliosLab logo
MEDP vs. PEN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MEDP and PEN is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MEDP vs. PEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and Penumbra, Inc. (PEN). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MEDP:

-0.51

PEN:

1.00

Sortino Ratio

MEDP:

-0.49

PEN:

1.52

Omega Ratio

MEDP:

0.93

PEN:

1.18

Calmar Ratio

MEDP:

-0.59

PEN:

0.66

Martin Ratio

MEDP:

-0.97

PEN:

4.54

Ulcer Index

MEDP:

24.11%

PEN:

7.59%

Daily Std Dev

MEDP:

43.74%

PEN:

39.71%

Max Drawdown

MEDP:

-42.87%

PEN:

-62.64%

Current Drawdown

MEDP:

-33.16%

PEN:

-18.42%

Fundamentals

Market Cap

MEDP:

$8.79B

PEN:

$10.87B

EPS

MEDP:

$13.11

PEN:

$1.07

PE Ratio

MEDP:

23.32

PEN:

262.32

PEG Ratio

MEDP:

3.51

PEN:

-62.27

PS Ratio

MEDP:

4.07

PEN:

8.77

PB Ratio

MEDP:

14.80

PEN:

8.96

Total Revenue (TTM)

MEDP:

$2.16B

PEN:

$1.24B

Gross Profit (TTM)

MEDP:

$672.28M

PEN:

$787.25M

EBITDA (TTM)

MEDP:

$484.51M

PEN:

$72.64M

Returns By Period

In the year-to-date period, MEDP achieves a -8.00% return, which is significantly lower than PEN's 18.19% return.


MEDP

YTD

-8.00%

1M

3.17%

6M

-1.60%

1Y

-22.28%

5Y*

28.67%

10Y*

N/A

PEN

YTD

18.19%

1M

1.20%

6M

18.01%

1Y

37.91%

5Y*

10.16%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MEDP vs. PEN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
The Risk-Adjusted Performance Rank of MEDP is 2121
Overall Rank
The Sharpe Ratio Rank of MEDP is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 2222
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 2121
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 1313
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 2727
Martin Ratio Rank

PEN
The Risk-Adjusted Performance Rank of PEN is 7979
Overall Rank
The Sharpe Ratio Rank of PEN is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 7878
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 7373
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 7676
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MEDP vs. PEN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Penumbra, Inc. (PEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MEDP Sharpe Ratio is -0.51, which is lower than the PEN Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of MEDP and PEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

MEDP vs. PEN - Dividend Comparison

Neither MEDP nor PEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MEDP vs. PEN - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum PEN drawdown of -62.64%. Use the drawdown chart below to compare losses from any high point for MEDP and PEN. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MEDP vs. PEN - Volatility Comparison

Medpace Holdings, Inc. (MEDP) has a higher volatility of 13.42% compared to Penumbra, Inc. (PEN) at 10.58%. This indicates that MEDP's price experiences larger fluctuations and is considered to be riskier than PEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MEDP vs. PEN - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Penumbra, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M20212022202320242025
558.57M
324.14M
(MEDP) Total Revenue
(PEN) Total Revenue
Values in USD except per share items

MEDP vs. PEN - Profitability Comparison

The chart below illustrates the profitability comparison between Medpace Holdings, Inc. and Penumbra, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
31.9%
66.6%
(MEDP) Gross Margin
(PEN) Gross Margin
MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a gross profit of 178.35M and revenue of 558.57M. Therefore, the gross margin over that period was 31.9%.

PEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a gross profit of 215.88M and revenue of 324.14M. Therefore, the gross margin over that period was 66.6%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported an operating income of 113.52M and revenue of 558.57M, resulting in an operating margin of 20.3%.

PEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported an operating income of 40.35M and revenue of 324.14M, resulting in an operating margin of 12.5%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a net income of 114.60M and revenue of 558.57M, resulting in a net margin of 20.5%.

PEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a net income of 39.22M and revenue of 324.14M, resulting in a net margin of 12.1%.